Proteomics at 9-month high on securing US patent for diagnostic test

Proteomics International Laboratories

17/12/2025 24:13

** Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February

** Medical technology firm secures U.S. patent for PromarkerEso diagnostic test
for early diagnosis of esophageal cancer

** Stock is down 28.8% YTD,  including the session's moves

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com; ))